Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Blood Coagul Fibrinolysis ; 35(6): 297-302, 2024 Sep 01.
Article in English | MEDLINE | ID: mdl-39083046

ABSTRACT

Cancer-associated thrombosis (CAT) is a common complication and a major cause of morbidity and mortality in patients with active cancers. CAT is common in various malignancies, particularly pancreatic, ovarian, gastric, colorectal, and hematologic cancers. In fact, CAT is a complicated multifactorial complication that may be influenced by the type of cancer as well as by the genetic background and inheritance of thrombophilic variants and elevated concentrations of coagulation factors. Several studies have shown the prominent role of inherited thrombophilias, such as prothrombin 20210, factor V Leiden, factor XIII Val34Leu, MTHFR C677T, in the occurrence of CAT, while others have found no correlation between them and CAT. In the present review, we have attempted to investigate the possible role of inherited thrombophilia in the occurrence of CAT.


Subject(s)
Neoplasms , Thrombophilia , Thrombosis , Humans , Thrombophilia/complications , Thrombophilia/genetics , Thrombophilia/blood , Neoplasms/complications , Neoplasms/genetics , Neoplasms/blood , Thrombosis/etiology , Factor V/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/genetics
2.
BMC Genom Data ; 23(1): 83, 2022 11 29.
Article in English | MEDLINE | ID: mdl-36443682

ABSTRACT

INTRODUCTION: The biology of colorectal cancer (CRC) is remained to be elucidated. Numerous genetic and epigenetic modifications are in concert to create and progress CRC. DNA methylation as a principal epigenetic factor has gained increased attention and could be utilized for biological studies. This study aims to find novel methylated and downregulated genes with a focus on HAND2 in CRC and decipher the biological consequences. MATERIAL AND METHOD: Data on DNA methylation from GEO and SMART databases and the expression GEPIA2 database were downloaded. Afterward, a set of hypermethylated and downregulated genes in CRC was chosen by overlapping genes. Consequently, HAND2 was selected as a key gene for further investigation and confirmed with cell lines methylation and expression data. The functions of HAND2 were further analyzed using gene ontology analyses and the protein-protein interaction network. RESULTS: The methylation (p < 0.01) and expression (p < 0.01) of HAND2 are significantly varied in CRC compared to normal control. The correlation analysis (Pearson's correlation coefficient = -0.44, p = 6.6e-14) conveys that HAND2 significantly downregulated and has a reverse correlation with the methylation status of CpG islands. The biological process analysis of HAND2 target genes conveyed that disruption in HAND2 expression could dysregulate ERK1 and ERK2 signaling pathways. CONCLUSION: Together, the findings showed that DNA hypermethylation of HAND2 was critical evidence in CRC. Further validation and prospective studies are needed to utilize HAND2 methylation as a promising biomarker.


Subject(s)
Adenocarcinoma , Colonic Neoplasms , Humans , DNA Methylation/genetics , Computational Biology , Colonic Neoplasms/genetics , Adenocarcinoma/genetics , CpG Islands/genetics , Transcription Factors
SELECTION OF CITATIONS
SEARCH DETAIL